The reported longevity of the MSP1FL-induced IgM antibodies resembling the long half-life of IgMs in malaria-exposed people80, raises further hopes of IgM antibodies contributing to the putative efficacy of the MSP1FL-based vaccine. Here, CD40LG is linked to malaria.